Skip to main content

Advertisement

SpringerLink
Log in

Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma

  • Clinical Trial Report
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

In this phase I study, single-agent chemotherapy was conducted in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) using nedaplatin (NDP) and concomitant radiotherapy. The study sought to determine the maximum tolerated dose (MTD), recommended dose (RD) and the clinical efficacy of this treatment in locoregionally advanced NPC patients.

Experimental design

Twenty patients were enrolled. The eligibility criteria included local advanced NPC (stage III or IVa) without any previous treatment and an expected survival of ≥3 months. The regimen consisted of 1.8–2.0 Gy daily radiation for 5 days a week and NDP with dose escalation of 70–100 mg/m2 on day 1. The cycles were repeated every 21 days (day 1, day 22 and day 43) until the completion of chemoradiation. Dose-limiting toxicities (DLTs) included: grade 4 anemia; grade 4 neutropenia lasting for ≥5 days; grades 3 and 4 febrile neutropenia; grade 4 thrombocytopenia; grades 3–4 non-hematological toxicity (with the exception of alopecia, nausea) and any of the grade 5 responses.

Results

Ninety-five percent of the assessed patients experienced a treatment response. The median time to progression among all patients was 41.9 months. Two-year overall survival was 95 %, while the progression-free survival was 85 %. DLT included febrile neutropenia of grade 3. The RD of NDP was 90 mg/m2 during cycles 1–3.

Conclusion

NDP combined with radiotherapy and administered every 21 days for three cycles was active in patients with locoregionally advanced NPC. The regimen resulted in mild adverse effects and good patient compliance. Based on the findings from the study, the RD of NDP for phase II trial was found to be 90 mg/m2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Xu J, He X, Cheng K, Guo W, Bian X, Jiang X, Zhang L, Huang S (2014) Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: survival and toxicity. Head Neck 36(10):1474–1480

    PubMed  Google Scholar 

  2. Zhang L, Chen QY, Liu H, Tang LQ, Mai HQ (2013) Emerging treatment options for nasopharyngeal carcinoma. Drug Des Dev Ther 7:37–52

    CAS  Google Scholar 

  3. Tham IW, Lu JJ (2010) Controversies and challenges in the current management of nasopharyngeal cancer. Expert Rev Anticancer Ther 10(9):1439–1450

    Article  PubMed  Google Scholar 

  4. Al-Sarraf M, Pajak TF, Cooper JS, Mohiuddin M, Herskovic A, Ager PJ (1990) Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study. J Clin Oncol Off J Am Soc Clin Oncol 8(8):1342–1351

    CAS  Google Scholar 

  5. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol Off J Am Soc Clin Oncol 16(4):1310–1317

    CAS  Google Scholar 

  6. Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET, Yang E, Lee KM, Fong KW, Tan HS, Lee KS, Loong S, Sethi V, Chua EJ, Machin D (2005) Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol Off J Am Soc Clin Oncol 23(27):6730–6738

    Article  CAS  Google Scholar 

  7. Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, Jones C, Ang KK (2009) Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol Off J Am Soc Clin Oncol 27(22):3684–3690

    Article  Google Scholar 

  8. Yan M, Kumachev A, Siu LL, Chan KK (2015) Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: a Bayesian network meta-analysis. Eur J Cancer 51(12):1570–1579

    Article  PubMed  Google Scholar 

  9. Chen L, Hu CS, Chen XZ, Hu GQ, Cheng ZB, Sun Y, Li WX, Chen YY, Xie FY, Liang SB, Chen Y, Xu TT, Li B, Long GX, Wang SY, Zheng BM, Guo Y, Mao YP, Tang LL, Chen YM, Liu MZ, Ma J (2012) Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol 13(2):163–171

    Article  PubMed  Google Scholar 

  10. Cao KJ, Zhang AL, Ma WJ, Huang PY, Luo DH, Xia WX (2011) Nedaplatin or cisplatin combined with 5-fluorouracil for treatment of stage III-IVa nasopharyngeal carcinoma: a randomized controlled study. Zhonghua Zhong Liu Za Zhi 33(1):50–52

    CAS  PubMed  Google Scholar 

  11. Ratain MJ, Mick R, Schilsky RL, Siegler M (1993) Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents. J Natl Cancer Inst 85(20):1637–1643

    Article  CAS  PubMed  Google Scholar 

  12. Chan AT, Leung SF, Ngan RK, Teo PM, Lau WH, Kwan WH, Hui EP, Yiu HY, Yeo W, Cheung FY, Yu KH, Chiu KW, Chan DT, Mok TS, Yau S, Yuen KT, Mo FK, Lai MM, Ma BB, Kam MK, Leung TW, Johnson PJ, Choi PH, Zee BC (2005) Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97(7):536–539

    Article  CAS  PubMed  Google Scholar 

  13. Chan AT, Gregoire V, Lefebvre JL, Licitra L, Hui EP, Leung SF, Felip E (2012) Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol ESMO 23(Suppl 7):vii83–vii85

    Article  Google Scholar 

  14. Peng PJ, Ou XQ, Chen ZB, Liao H, Peng YL, Wang SY, Zhang HY, Lin Z (2013) Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy. Cancer Chemother Pharmacol 72(2):323–328

    Article  CAS  PubMed  Google Scholar 

  15. Isobe K, Kawakami H, Uno T, Yasuda S, Aruga T, Ueno N, Kawata T, Ito H (2003) Concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: Is intergroup study 0099 feasible in Japanese patients? Jpn J Clin Oncol 33(10):497–500

    Article  PubMed  Google Scholar 

  16. Ali BH, Al Moundhri MS (2006) Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol Int J Publ Br Ind Biol Re Assoc 44(8):1173–1183

    Article  CAS  Google Scholar 

  17. Boulikas T, Vougiouka M (2003) Cisplatin and platinum drugs at the molecular level. Oncol Rep 10(6):1663–1682 (Review)

    CAS  PubMed  Google Scholar 

  18. Ali I, Wani WA, Saleem K, Haque A (2013) Platinum compounds: a hope for future cancer chemotherapy. Anti Cancer Agents Med Chem 13(2):296–306

    Article  CAS  Google Scholar 

  19. Alberto ME, Lucas MF, Pavelka M, Russo N (2009) The second-generation anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism. J Phys Chem B 113(43):14473–14479

    Article  CAS  PubMed  Google Scholar 

  20. Kawai Y, Taniuchi S, Okahara S, Nakamura M, Gemba M (2005) Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation. Biol Pharm Bull 28(8):1385–1388

    Article  CAS  PubMed  Google Scholar 

  21. Sato D, Kogashiwa Y, Tsukahara K, Yamauchi K, Kohno N (2013) Phase I study of nedaplatin prior to S-1 in patients with locally advanced head and neck squamous cell carcinoma. Chemotherapy 59(4):314–318

    Article  CAS  PubMed  Google Scholar 

  22. Fuwa N, Kodaira T, Tachibana H, Nakamura T, Daimon T (2007) Dose escalation study of nedaplatin with 5-fluorouracil in combination with alternating radiotherapy in patients with head and neck cancer. Jpn J Clin Oncol 37(3):161–167

    Article  PubMed  Google Scholar 

  23. Teramoto K, Asada Y, Ozaki Y, Suzumura Y, Nakano Y, Sawai S, Tezuka N, Inoue S, Fujino S (2012) A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer. Cancer Chemother Pharmacol 70(4):531–537

    Article  CAS  PubMed  Google Scholar 

  24. Zhang MQ, Liu SP, Wang XE (2010) Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study. Int J Radiat Oncol Biol Phys 78(3):821–827

    Article  PubMed  Google Scholar 

  25. Ota K, Wakui A, Majima H, Niitani H, Inuyama Y, Ogawa M, Ariyoshi Y, Yoshida O, Taguchi T, Kimura I (1992) Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II). Gan to kagaku ryoho Cancer Chemother 19(6):8558–8561

    Google Scholar 

  26. Nwizu T, Adelstein DJ (2014) In squamous cell head and neck cancer: Which platinum, how much and how often? Expert Rev Anticancer Ther 14(9):1033–1039

    Article  CAS  PubMed  Google Scholar 

  27. Adachi M, Shibata A, Hayashi M, Satoh D, Miyasaka T, Yanai C, Kawatsu N, Yagishita H, Ogino Y, Yamashita N, Suzuki M (2002) Combined preoperative therapy for oral cancer with nedaplatin and radiation. Gan to kagaku ryoho Cancer Chemother 29(3):465–467

    Google Scholar 

  28. Zheng J, Wang G, Yang GY, Wang D, Luo X, Chen C, Zhang Z, Li Q, Xu W, Li Z (2010) Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Jpn J Clin Oncol 40(5):425–431

    Article  PubMed  Google Scholar 

  29. Kodama J, Takemoto M, Seki N, Nakamura K, Hongo A, Moriya S, Kanazawa S, Hiramatsu Y (2008) Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 18(6):1300–1304

    Article  CAS  Google Scholar 

  30. Kogashiwa Y, Yamauchi K, Nagafuji H, Matsuda T, Tsubosaka T, Karaho T, Maruyama T, Kohno N (2010) Phase I study of S-1 plus nedaplatin in patients with advanced/recurrent head and neck cancer. Chemotherapy 56(6):453–458

    Article  CAS  PubMed  Google Scholar 

  31. Miyazaki T, Sohda M, Tanaka N, Suzuki S, Ieta K, Sakai M, Sano A, Yokobori T, Inose T, Nakajima M, Fukuchi M, Ojima H, Kato H, Kuwano H (2013) Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer. Cancer Chemother Pharmacol 71(4):853–857

    Article  CAS  PubMed  Google Scholar 

  32. Shimada M, Fujiwara H, Sato S, Oishi T, Itamochi H, Machida S, Takei Y, Harada T, Suzuki M, Kigawa J (2012) Area under the curve calculation of nedaplatin dose used in combination chemotherapy with irinotecan in a phase I study of gynecologic malignancies. Cancer Chemother Pharmacol 70(1):33–38

    Article  CAS  PubMed  Google Scholar 

  33. Ueda S, Kawakami H, Nishina S, Sakiyama T, Nonagase Y, Okabe T, Tamura T, Nakagawa K (2015) Phase I trial of 5-FU, docetaxel, and nedaplatin (UDON) combination therapy for recurrent or metastatic esophageal cancer. Cancer Chemother Pharmacol 76(2):279–285

    Article  CAS  PubMed  Google Scholar 

  34. Takeda Y, Kasai H, Uchida N, Yoshida H, Maekawa R, Sugita K, Yoshioka T (1999) Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts. Anticancer Res 19(5B):4059–4064

    CAS  PubMed  Google Scholar 

  35. Uchida N, Takeda Y, Hojo K, Maekawa R, Sugita K, Yoshioka T (1998) Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model. Eur J Cancer 34(11):1796–1801

    Article  CAS  PubMed  Google Scholar 

  36. Zhang Y, Yang Z, Zhou Y, Pan J, Liu Y (2015) Efficacy of concurrent single-agent chemotherapy using radiotherapy in patients with cervical cancer: a meta-analysis. Int J Clin Exp Med 8(6):8661–8673

    PubMed Central  PubMed  Google Scholar 

  37. Zheng J, Lin J, Wang L, Zhou J, Xie B, Xu T, Zhang W (2014) Metastatic nasopharyngeal carcinoma outcomes in patients on cisplatin with nolatrexed or 5-fluorouracil. Oncol Res Treat 37(10):540–544

    Article  CAS  PubMed  Google Scholar 

  38. Ciuleanu TE, Fountzilas G, Ciuleanu E, Plataniotis M, Todor N, Ghilezan N (2004) Paclitaxel and carboplatin in relapsed or metastatic nasopharyngeal carcinoma: a multicenter phase II study. J BUON 9(2):161–165

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (NSFC) Grant (81271476), Guangzhou Science and Technology Research Grant (201300000154) and the 111 Project Grant (B13037).

Author information

Author notes

    Authors and Affiliations

    1. Department of Anatomy and Neurobiology, Sun Yat-sen University, Guangzhou, 510080, China

      Zibin Liang, Yaqi Yang, Ying Kuang, Chibhabha Fidelis, Shahid Ullah & Feng Li

    2. Guangdong Provincial Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China

      Feng Li

    3. Department of Radiation Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, 519020, China

      Zibin Liang, Siyang Wang & Zhibin Cheng

    4. Department of Medical Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, 519020, China

      Zhong Lin

    5. Department of Otolaryngology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, 519020, China

      Shaoyan Feng

    Authors
    1. Zibin Liang
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Siyang Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Zhong Lin
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Shaoyan Feng
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Zhibin Cheng
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Yaqi Yang
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Ying Kuang
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Chibhabha Fidelis
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Shahid Ullah
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Feng Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Feng Li.

    Additional information

    Zibin Liang and Siyang Wang have contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Liang, Z., Wang, S., Lin, Z. et al. Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma. Cancer Chemother Pharmacol 77, 643–651 (2016). https://doi.org/10.1007/s00280-016-2971-4

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00280-016-2971-4

    Keywords

    Search

    Navigation